melanotan 2 peptide 99.9 II (MT-II) Therapy Melanotan 2 (MT-II) | ≥99%
Description
LINDLEY, BARBARA M., Greenville, N.C

The high OCTN2 expression is associated with poor overall patient survival and a siRNA-mediated OCTN2 silencing in GBM led to a loss of tumor cell viability (Wang et al., 2012)

doi: 10.1038/ajg.2009.719

A treatment can take as little as a few minutes to as long as an hour, depending on how many areas you're treating
